<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940317-2-00069</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>National Institutes of Health</USBUREAU> <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 -->  <DOCTITLE>Special Meeting of the Acquired Immunodeficiency Syndrome Program Advisory Committee (APAC)</DOCTITLE> <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Pursuant to Public Law 92&hyph;463, notice is hereby given of a special meeting of the Acquired Immunodeficiency Syndrome (AIDS) Program Advisory Committee on March 31, 1994, at the National Institutes of Health (NIH), Bethesda, Maryland. The meeting will take place from 10 a.m. until 3 p.m. in Building 31, C Wing, Conference Room 9 to review human subjects protections under parallel track proposals. The meeting will be open to the public from 10 a.m. until 10:30 a.m. for a staff orientation on the parallel track initiative and the review of human subjects protections. Attendance by the public will be limited to space available. Please contact Rita Gant in the Office of AIDS Research at 301&hyph;496&hyph;0358, if you are planning to attend or if you need special assistance, such as sign language interpretation or other reasonable accommodations. <!-- PJG 0012 frnewline --> In accordance with the provisions set forth in section 552b(c)(4), title 5, U.S.C. and section 10(d) of Public Law 92&hyph;463, the meeting will be closed to the public from 10:30 a.m. until adjournment for the mandated annual review, discussion, and evaluation of an individual proposal for expanded availability of an investigational new AIDS drug through the parallel track mechanism. This proposal and subsequent discussion could reveal confidential trade secrets or commercial property such as patentable material. <!-- PJG 0012 frnewline --> Linda Reck, Senior Program Analyst, Office of AIDS Research, National Institutes of Health, Building 31, room 5C02, 9000 Rockville Pike, Bethesda, MD 20892, (301) 496&hyph;0358, will provide a summary of the meeting, a roster of committee members, and substantive program information upon request. <!-- PJG 0012 frnewline --> This notice is being published less than 15 days prior to the meeting due to the difficulty of coordinating the attendance of members because of conflicting schedules. <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: March 10, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Susan K. Feldman <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Committee Management Officer, NIH. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;6252 Filed 3&hyph;16&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4140&hyph;01&hyph;M <!-- PJG /ITAG --> </BILLING>  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            